GATEWAY INVESTOR FORUMS
A DIVISION OF

THE WALL STREET
TRANSCRIPT

PRESENTS

 INVESTING IN
HEALTHCARE
CONFERENCE
 March 25, 2003 ~ The Harvard Club, NYC
 27 West 44th Street, between Fifth and Sixth Avenues

View the Brochure (PDF)

Register for this event

The health care industry is enormous, as some $1 trillion a year or one-seventh of the nation’s GDP is directed to the industry.  Expenditures on health care are skyrocketing as health insurers and HMOs are demanding premium increases of as much as 20% annually.

Each sector of the industry – whether it be pharmaceuticals, medical devices, medical facility providers or medical service providers – is impacted differently by the technological innovation, FDA approval times, legislation, demographics, reimbursement and changes in related sectors of the health care industry.

The following are among the considerations that astute investors must take into account when investing in the health care sector:

  Scientific Breakthroughs

  • Will scientific breakthroughs be rewarded with patent protection?
  • Will new drugs or devices be reviewed by the FDA in a timely manner?
  • When will new drugs face competition from generics?
  • How quickly will practitioners adapt to new devices?
  • Will new drugs and devices be deemed eligible for reimbursement?

  Political Environment

  • How does media scrutiny force HMOs to offer more services?
  • How threatening will class action lawsuits become to HMOs? And to pharmaceutical manufacturers?

  Demographics

  • How will the aging of America affect hospital operators?  Rehabilitation providers?
  • Will seniors win across-the-board discounts on their prescriptions?

Don’t miss this rare opportunity to listen to leading analysts discuss how their sectors are positioned to navigate the road ahead.  Be sure to listen to leading executives discuss how they are positioning their companies for the future.

AGENDA

8:00am
Registration & Continental Breakfast

8:30am
Overview of the Pharmaceuticals Industry
Al Rauch - Managing Director, A.G. Edwards

9:10am
Texas Biotechnology (TXBI) 
Dr. Bruce D. Given, President, CEO & Director
An emerging pharmaceutical company that discovers, develops and commercializes small molecule drugs aimed at cardiovascular and inflammatory diseases.


9:50am
Dr.'s Natural Solutions
Dr. Aharon Friedman, President
Provides natural remedies for overweight, exhaustion and
high blood sugar ailments.


10:30am
Coffee Break

10:40am
Biopure Corporation (BPUR)
Ronald F. Richards, CFO & SVP- Business Development
A developer, manufacturer and marketer of oxygen therapeutics, which are intravenously administered to deliver oxygen to the body's tissues. 

11:20am
Overview of the Managed Services & Medical Facility Providers
Kip Hewitt - Managing Director, Legg Mason
Jerry L. Doctorow - Managing Director, Legg Mason

12:00pm
Medicure (T:MPH)
Albert D. Freisen, PhD., President, Chairman & CEO
A biotechnology company focused on the development of
drugs for inadequately treated cardiovascular diseases and stroke.

12:40pm
Buffet Lunch

1:30pm
Capital Senior Living (CSU)
Lawrence A. Cohen - CEO
One of the country's largest operators of senior housing communities.

2:10pm
An Overview of the Medical Devices Industry
Ron Opal - Managing Director, H.C. Wainwright

2:50pm
Afternoon Break

3:00pm
Bioject Medical Technologies (BJCT)
John Gandolfo - CFO
An emerging drug delivery company developing a technology for needle-free injection of liquid medications. 

3:40pm
An Overview of the Biotechnology Industry
Robert LeBoyer - Managing Director & Senior Biotechnology Analyst, InvestBio


4:20pm
NMT Medical (NMTI)
John Ahern - President & CEO
Designs, develops and markets innovative medical devices that utilize advanced technologies and are delivered by minimally invasive procedures. 

5:00pm
Adjournment

What are the most promising and profitable niches in the trillion dollar health care industry?

Leading securities analysts – from A.G. Edwards, H.C. Wainwright and Legg Mason – will discuss the dynamics impacting major segments of the health care industry - namely pharmaceuticals, medical device manufacturers, medical facility providers and medical service providers – at The Wall Street Transcript’s 2003 Investing in the Health Care Industry Conference on March 25 at The Harvard Club in mid-town New York City.

These seasoned health care investment professionals will discuss the impact of demographics, legislation, reimbursement and scientific advances on their sectors of expertise.  In addition, this conference will feature roadshow-like presentations delivered by senior executives from some of the nation’s most promising health care companies.  They will discuss their companies’ technology, business models, competition and plans for growth.

Save $100 from the registration fee of $295 by registering before March 19, 2003. Please click here to register.  For more information call Sam Seiler at (212) 952-7400, ext.127 or email seiler@twst.com. 

Attendees will include portfolio managers from pension funds, mutual funds, hedge funds and insurance companies as well as securities analysts from brokerage firms and investment banks.  With networking breaks and receptions built into the conference agenda, you will have plenty of opportunities to forge new professional relationships.

Don’t miss this unique opportunity to discover the dynamism and profit potential of health care leaders.

We look forward to seeing you on March 25.

Andrew Pickup
Publisher
The Wall Street Transcript

15 Reasons to Attend

  • Discover the market opportunities that patent expirations provide for generic drug manufacturers.
  • Learn how new co-pay schemes greatly benefit generics manufacturers.
  • Hear how increasingly stringent FDA inspections have resulted in shut-downs of pharmaceutical plants.
  • Learn the extent to which many states are demanding deep rebates on drugs prescribed for their Medicaid recipients.
  • Gain insight into the contributing factors of prolonged FDA approval times.
  • Identify new advances being championed by medical device manufacturers.
  • Discover which medical device makers should enjoy greater pricing power.
  • Hear how managed care providers are relying on tiering to control hospital care costs.
  • Understand why soaring HMO premiums are forcing growing numbers of employers to self-insure.
  • Obtain insight into the impact of benefit buydowns.
  • Understand the impact of traditionally non-profit insurers going for profit and even going public.
  • Discover the ramifications of hospitals being capacity constrained.
  • Discern why the nursing shortage is becoming less critical.
  • Learn why demographics are benefiting rehabilitation providers.
  • Detect trends in government reimbursement policy towards nursing home operators.


 Register for this event

Call (212) 952-7400 ext. 127 or Email seiler@twst.com